Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New eczema drug shows promise for Kids' itch relief

NCT ID NCT01840605

First seen Jan 11, 2026 · Last updated Jun 18, 2026 · Updated 26 times

Summary

This study tested a new medicine called TAU-284 to see if it could reduce itching in children with eczema (atopic dermatitis). About 300 children aged 7 to 15 took part. The goal was to compare TAU-284 to an existing medicine, ketotifen, to see if it worked just as well.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Medical Corporation Kojinkai Asanuma Dermatology Clinic

    Hokkaido, Japan

Conditions

The condition(s) this trial relates to.

atopic eczema atopic IgE-mediated allergic disorder dermatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.